|
3A Rare Look into New Guidances: The Future State of Orphan Drug Development, Upcoming Webinar Hosted by Xtalks
Thursday, February 13, 2025
In this free webinar, learn about the rare disease landscape, including 2024 approval trends. Attendees will gain insights into the key regulatory guidances published within the past year and their impact on rare disease clinical research. The featured speakers will share study design strategies to ensure efficiency and compliance. Attendees will also hear a medic's perspective on what the changes will mean for patients and investigators.
TORONTO, Feb. 5, 2025 /PRNewswire-PRWeb/ -- Rare disease drug development is evolving, driven by innovation and regulatory advancements. With many devastating rare diseases still lacking approved treatments, regulatory agencies are taking significant steps to support innovators, advance research and improve patient outcomes. Through updated and newly developed guidances, they aim to provide a roadmap for navigating the complexities of this specialized field.
Register for this webinar to explore how the rare disease landscape is changing with guidance from AI, accelerated approval pathways and fostering DEI in clinical research.In this webinar, they will highlight key regulatory guidances published within the past year, addressing artificial intelligence (AI), accelerated approval pathways and fostering diversity, equity and inclusion (DEI) in clinical research. Attendees will gain insights into the challenges these guidances aim to address, their potential to transform the rare disease landscape, and strategies for incorporating any necessary changes into drug development programs.
Register for this webinar to explore how the rare disease landscape is changing with guidance from AI, accelerated approval pathways and fostering DEI in clinical research.
Join experts from Premier Research, Adam Bloomfield, MD, FAAP, Vice President, General Medicine, Rare Disease and Pediatrics, Medical Affairs; Leslie Wetherell, Executive Director, Program Strategy, Rare Disease and Pediatrics; Paulla Dennis, Executive Director, Program Strategy, Rare Disease, Pediatrics, Cell and Gene Therapy, for the live webinar on Tuesday, February 25, 2025, at 11am EST (4pm GMT/UK).
For more information, or to register for this event, visit A Rare Look into New Guidances: The Future State of Orphan Drug Development.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com, https://xtalks.com
View original content to download multimedia:https://www.prweb.com/releases/3a-rare-look-into-new-guidances-the-future-state-of-orphan-drug-development-upcoming-webinar-hosted-by-xtalks-302368632.html
SOURCE Xtalks
|
|
|
|
|
|
 |
VIAVI Highlights Test Solutions for AI Infrastructure Development, Manufacturing and Deployment at OFC 2025 | Mar 28, 2025
|
|
Orium Launches Composable Accelerator for Shopify | Mar 28, 2025
|
|
ThreatQuotient positioned as a Leader in the SPARK Matrix(TM): Digital Threat Intelligence Management, 2025 by QKS Group | Mar 28, 2025
|
|
Oracle Helps Customers Boost Employee Engagement with Strategic Communications and Internal Events | Mar 28, 2025
|
|
Madame Rachida Dati, French Minister of Culture, has granted official recognition to thierry Ehrmann's Abode of Chaos as a 'total work of art', the global headquarters of Artprice by Artmarket. | Mar 28, 2025
|
|
Datacenter Dynamics Makes History with LoneStar - Becoming the World's First Magazine to Reach the Moon | Mar 28, 2025
|
|
Oracle Named a Leader in Configure, Price, Quote by Independent Research Firm | Mar 28, 2025
|
|
Nosto reports 323% growth of Personalized Search after 2024 Gartner MQ inclusion | Mar 28, 2025
|
|
Western Union forms strategic partnership with HCLTech to transition to an AI led platform operating model | Mar 28, 2025
|
|
Wealthbox Expands to Canada with In-Country Data Hosting | Mar 28, 2025
|
|
|
|
